Danish Aerospace and Defence Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; shuttle ergometer; and flight ergometer, the next generation space ergometer. The company provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. The company was formerly known as Danish Aerospace Company A/S and changed its name to Danish Aerospace and Defence Company A/S in May 2026. The company was founded in 1988 and is based in Odense, Denmark.…
Danish Aerospace and Defence Company A/S updates the guidance for 2026 and issues preliminary guidance for 2027
Danish Aerospace and Defence Company (CPH: DADC) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 24 employees.
The shares were at 1.800 DKK on 20 November 2026, down 78.9% over 52 weeks. Its 52-week range is 1.800 DKK to 10.50 DKK, and it trades at the bottom of that range.
Its market capitalisation is 34.60M DKK.
Danish Aerospace and Defence Company reports return on equity of -52.4%, an operating margin of -29.3% and revenue down 15.8% year over year.
Its debt exceeds its cash by 1.14M DKK, a debt-to-equity ratio of 1.74. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.